Kuhlmann J
Dtsch Med Wochenschr. 1984 Jan 13;109(2):59-61. doi: 10.1055/s-2008-1069139.
In ten patients in heart failure for which they were on long-term administration of digitoxin, the influence of aluminium-magnesium hydroxide gel (Maaloxan) on steady-state digitoxin plasma concentration and renal glycoside excretion was studied. Compared with control values before antacid medication (13.6 +/- 4.4 ng/ml), the administration of 20 ml aluminium-magnesium hydroxide gel three or four times daily for several weeks caused no significant change in digitoxin plasma levels (15.1 +/- 4.9 ng/ml). Daily renal glycoside excretion, as a further measure of bioavailability of digitoxin, was also unchanged by the antacid. Therapeutic plasma concentrations of digitoxin are not influenced by antacids which contain aluminium-magnesium hydroxide, at least not if the antacid is taken 1-2 hours after the digitoxin dose.
在10例因心力衰竭而长期服用洋地黄毒苷的患者中,研究了氢氧化铝镁凝胶(Maaloxan)对洋地黄毒苷稳态血药浓度及肾脏糖苷排泄的影响。与服用抗酸药前的对照值(13.6±4.4 ng/ml)相比,连续数周每天3或4次服用20 ml氢氧化铝镁凝胶后,洋地黄毒苷血药水平无显著变化(15.1±4.9 ng/ml)。作为洋地黄毒苷生物利用度的另一项指标,每日肾脏糖苷排泄量也未因抗酸药而改变。至少在洋地黄毒苷给药后1 - 2小时服用抗酸药的情况下,含氢氧化铝镁的抗酸药不会影响洋地黄毒苷的治疗血药浓度。